Low-Dose Cyclophosphamide versus Intermediate-High-Dose Cyclophosphamide versus Granulocyte Colony-Stimulating Factor Alone for Stem Cell Mobilization in Multiple Myeloma in the Era of Novel Agents: A Multicenter Retrospective Study

Authors:

Abstract
No abstract available
Funding Information
  • AbbVie

This publication has 43 references indexed in Scilit: